Survival, response and immune effects in a prospectively randomized study of dose strategy for alpha-N1 interferon

Several tumour sites have now demonstrated objective responses to alpha interferons in a diversity of doses and schedules. Since effectiveness should be enhanced with the identification of an optimal dose strategy, we undertook a prospectively randomized study to compare an intermittent high dose es...

Ausführliche Beschreibung